Global /China /Healthcare /Drug Manufacturers - General /1666

Tong Ren Tang Technologies Co. Ltd.

1666

• SHEK: 1666 • Delayed

3.84HKD -0.3%

0.4900 USD

As of 14 June 2026, Tong Ren Tang Technologies Co. Ltd. has a market cap of $629.18M USD, ranking #13641 globally and #4156 in China. It ranks #1223 in the Healthcare sector, and #455 in the Drug Manufacturers - General industry.

Global Rank

13641

Country Rank

4156

Sector Rank

1223

Industry Rank

455

Key Stats

Market Cap

$629.18MUSD

4.93B HKD

Enterprise Value

$642.78MUSD

5.04B HKD

Revenue (TTM)

$920.65MUSD

7.22B HKD

EBITDA (TTM)

$141.0MUSD

1.1B HKD

Net Income (TTM)

$56.27MUSD

440.98M HKD

EBITDA Margin

15%

Profit Margin

6.1%

PE Ratio

11.2

Forward PE

9.6

PS Ratio

0.7

PB Ratio

0.4

EV/EBITDA

4.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jia Fu Chen open_in_new

Employees

3,888

Founded

1669

Website

tongrentangkj.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-2.3%	-4.2%	-12%	-17%	-13%	-20%	-55%	-40%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	1666 北京同仁堂科技发展股份有限公司 Class H ISIN: CNE100000585 Shares Out.: Shares Outstanding: 628.704M¹ Shares Float: 585.323M² TV: TradingView: HKEX: 1666 SA: Stock Analysis: HKG: 1666 YF: Yahoo Finance: 1666.HK GF: Google Finance: HKG: 1666 BA: Barron's: 1666 MS: Morningstar: XHKG: 01666	3.84 HKD	TV: TradingView: HKEX: 1666 SA: Stock Analysis: HKG: 1666 YF: Yahoo Finance: 1666.HK GF: Google Finance: HKG: 1666 BA: Barron's: 1666 MS: Morningstar: XHKG: 01666
OTC Markets (OTCMKTS / OTC) MIC: OTCM	TGRNF 北京同仁堂科技发展股份有限公司 Class H ISIN: CNE100000585 TV: TradingView: OTC: TGRNF SA: Stock Analysis: OTC: TGRNF YF: Yahoo Finance: TGRNF GF: Google Finance: OTCMKTS: TGRNF BA: Barron's: TGRNF MS: Morningstar: PINX: TGRNF	0.7000 USD	TV: TradingView: OTC: TGRNF SA: Stock Analysis: OTC: TGRNF YF: Yahoo Finance: TGRNF GF: Google Finance: OTCMKTS: TGRNF BA: Barron's: TGRNF MS: Morningstar: PINX: TGRNF
Frankfurt Stock Exchange (FRA) MIC: XFRA	TNG 北京同仁堂科技发展股份有限公司 Class H ISIN: CNE100000585 TV: TradingView: FWB: TNG SA: Stock Analysis: FRA: TNG YF: Yahoo Finance: TNG.F GF: Google Finance: FRA: TNG BA: Barron's: TNG MS: Morningstar: XFRA: TNG	0.4020 EUR	TV: TradingView: FWB: TNG SA: Stock Analysis: FRA: TNG YF: Yahoo Finance: TNG.F GF: Google Finance: FRA: TNG BA: Barron's: TNG MS: Morningstar: XFRA: TNG

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tong Ren Tang Technologies Co. Ltd.

Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through The Company; Tong Ren Tang Chinese Medicine; and Others segments. The company also develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products; and offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics. In addition, it provides medical research and development; advertisement; and Chinese medical consultations and treatments. Further, the company produces and processes biochemical products; extracts and processes plants; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People’s Republic of China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 8K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 8K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 121K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 87K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 57K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 51K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 46K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 44K%	20.5	Switzerland

chevron_leftBack